Advertisement
Advertisement

DRRX

DRRX logo

Durect Corp

0.8302
USD
-0.0109
-1.30%
Jan 23, 10:01 UTC -5
Open

Durect Corp Profile

About

Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.

Info & Links

CEO

James E. Brown

Headquarters

10240 BUBB ROAD
CUPERTINO, CA 95014, UNITED STATES

Auditor

ERNST & YOUNG LLP

Share holders

71

Employees

58

Durect Corp Statistics

Valuation Measures

Market Capitalization2

25.77M

Enterprise Value

27.15M

Enterprise Value/EBITDA(ttm)

-1.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

3.04

Price to Book(mrq)

21.47

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

79.13%

Operating Margin(ttm)

-256.55%

Profit Margin(ttm)

-216.28%

Return on Equity(ttm)

-300.62%

Return on Invested Capital(ttm)

-527.38%

Return on Assets(ttm)

-65.17%

Income Statement

Revenue(ttm)

8.59M

Revenue Per Share(ttm)

0.28

Gross Profit(ttm)

6.78M

EBITDA(ttm)3

-19.04M

Net Income Available to Common(ttm)

-17.07M

Diluted EPS(ttm)

-0.61

Share Statistics

Beta (5Y Monthly)

0.94

52-Week Change

25.58%

S&P 500 52-Week Change

25.30%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

31.04M

Dividend Yield

0.00%

Float4

30.05M

% Held by Insiders

3.20%

% Held by Institutions

28.03%

Balance Sheet

Total Cash(mrq)

10.38M

Total Cash Per Share(mrq)

0.33

Total Debt(mrq)

10.47M

Total Debt/Equity(mrq)

859.98%

Current Ratio(mrq)

0.71%

Quick Ratio(mrq)

0.60%

Book Value Per Share(mrq)

0.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.44

Free Cash Flow(ytd)

-13.57M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement